NASDAQ$OPTX

Syntec Optics Holdings Inc · Q2 2024 earnings

Q2 2024 earnings · · Investor relations

Briefing

Achieved sequential revenue growth and returned to positive EBITDA and Earnings per Share.

Syntec Optics reported a net sales of $7.01 million for Q2 2024, a 12% increase compared to Q1 2024. The company achieved an adjusted EBITDA of $1.32 million and a net income of $0.3 million, or $0.01 per share, up from negative $1.2 million or negative $0.03 per share for Q1 2024.

  • Net sales for Q2 2024 were $7.01 million, a 12% increase compared to $6.3 million in Q1 2024.
  • Product revenue increased by 20% to $7.0 million compared to $5.8 million in Q2 2023.
  • Adjusted EBITDA for Q2 2024 was $1.32 million, compared to a negative $0.7 million in Q1 2024.
  • Net income for Q2 2024 was $0.3 million, or $0.01 per share, up from negative $1.2 million, or negative $0.03 per share for Q1 2024.

Headline financials

Total Revenue

$0.00

Previous: $0.00
EPS (adj)

$0.01

Previous: $0.02-50.0%
Capital Expenditures

-$255K

Previous: $0.00
Free Cash Flow

$27.1K

Previous: -$279K+109.7%
Net Income

$282K

Previous: -$258K+209.2%
Operating Income

$159K

Previous: -$367K+143.2%
Gross Profit

$2.17M

Previous: $0.00
Cash & Equivalents

$830K

Previous: $468K+77.5%
Total Assets

$25.8M

Previous: $14.9M+73.4%

Revenue & EPS history

Syntec Optics · Revenue · Quarterly

$0

Q2 2024

Revenue by segment

Syntec Optics · $6.51M total across 4 segments · Q1 2026

  • Communication
    $1.84M
  • Consumer
    $1.59M
  • Defense
    $1.56M
  • Medical
    $1.52M

Forward guidance

The company expects Q3 2024 revenue to be in the range of $9.5 - $11.0 million and anticipates continued strength from the communications and biomedical end-markets in Q4, with additional growth coming from defense-based product launches. Positive net income is expected in the second half of the year.

Tailwinds

  • Ongoing sales into the communications, medical, and defense industries are expected to accelerate in the third quarter.
  • Space communications optics and datacom microlens arrays are expected to drive growth in Q3.
  • Gross margin is expected to hold level or slightly improve based on the profitability of ramping up products.
  • Continued strength is anticipated from the communications and biomedical end-markets in Q4.
  • Additional growth is expected from defense-based product launches in Q4.

Headwinds

  • General and administrative costs are expected to increase modestly to enable ramped-up engineering, quality, and pilot production to support continued growth in the third quarter.
  • Decrease in custom tooling revenue compared to the prior year.
  • Decrease in non-recurring engineering revenue compared to the prior year.
  • Year-over-year decrease in adjusted EBITDA due to a decrease in gross profit.
  • Year-over-year increase in general and administrative expenses.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 10 quarterly earnings reports · overlaid with Q2 2024

Historical avgQ2 2024

-2.6%

Avg return

Earnings day

-3.7%

Avg return

5 days after

-9.6%

Avg return

30 days after

18%

2 / 11 earnings

Positive

+68.5%

Q2 2024

Best reaction

-32.9%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-6.3%+17.6%
Q3 2025-5.0%-32.0%-24.1%
Q2 2025-6.1%+4.1%+22.5%
Q1 2025-16.3%-22.2%+7.5%
Q3 2024-32.9%-40.7%-36.4%
Q2 2024+68.5%+66.7%+26.9%
Q4 2023-7.0%-13.7%-0.7%
Q4 2022-7.0%-0.9%-20.7%
Q1 2024+0.3%+4.4%-19.0%
Q3 2023-17.0%-23.9%-51.8%
Q2 2023-0.2%-0.2%-0.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro